Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice
Hong Shen, … , M. Bishr Omary, Liangyou Rui
Hong Shen, … , M. Bishr Omary, Liangyou Rui
Published March 19, 2019
Citation Information: J Clin Invest. 2019;129(6):2305-2317. https://doi.org/10.1172/JCI124376.
View: Text | PDF
Research Article Hepatology Article has an altmetric score of 35

Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice

  • Text
  • PDF
Abstract

Chronic alcohol consumption causes liver injury, inflammation, and fibrosis, thereby increasing morbidity and mortality. Paradoxically, modest drinking is believed to confer metabolic improvement, but the underlying mechanism remains elusive. Here, we have identified a hepatoprotective brain/brown adipose tissue (BAT)/liver axis. Alcohol consumption or direct alcohol administration into the brain stimulated hypothalamic neural circuits and sympathetic nerves innervating BAT and dramatically increased BAT uncoupling protein 1 (Ucp1) expression and activity in a BAT-sympathetic nerve-dependent manner. BAT and beige fat oxidized fatty acids to fuel Ucp1-mediated thermogenesis, thereby inhibiting lipid trafficking into the liver. BAT also secreted several adipokines, including adiponectin, which suppressed hepatocyte injury and death. Genetic deletion of Ucp1 profoundly augmented alcohol-induced liver steatosis, injury, inflammation, and fibrosis in male and female mice. Conversely, activation of BAT and beige fat through cold exposure suppressed alcoholic liver disease development. Our results unravel an unrecognized brain alcohol-sensing/sympathetic nerve/BAT/liver axis that counteracts liver steatosis and injury.

Authors

Hong Shen, Lin Jiang, Jiandie D. Lin, M. Bishr Omary, Liangyou Rui

×

Figure 6

Brain alcohol-sensing activates BAT.

Options: View larger image (or click on image) Download as PowerPoint
Brain alcohol-sensing activates BAT.
(A–B) Differentiated (A) and primar...
(A–B) Differentiated (A) and primary (B) brown adipocytes were treated with ethanol for 5–18 hours. Ucp1 mRNA levels were measured by qPCR and normalized to 18S levels (n = 3 per group). (C–G) C57BL/6 male mice were housed at 30°C and centrally administrated with alcohol for 3 weeks. (C) BAT TAG levels (normalized to BAT weight; n = 5 per group). (D) Representative BAT sections. TH areas were normalized to the total areas (n = 3 mice per group). (E) BAT extracts were immunoblotted with the indicated antibodies. (F) BAT gene expression (normalized to 18S levels; n = 4–5 per group). (G) BAT OCR (normalized to BAT weight, n = 5 mice per group). (H, I) C57BL/6 males were centrally injected with alcohol, and brains were harvested 2 hours later. Brain sections were stained with anti–c-Fos antibody, and c-Fos+ cells were quantified in different hypothalamic areas. PBS, n = 3; EtOH, n = 3. Scale bars: 200 μm. Data are presented as mean ± SEM. *P < 0.05, 2-tailed unpaired Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 3 news outlets
Posted by 21 X users
On 2 Facebook pages
76 readers on Mendeley
See more details